期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 44, 期 12, 页码 4937-4943出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2009.08.008
关键词
Chagas disease; Ruthenium complexes; 5-Nitrofuryl containing thiosemicarbazones
资金
- TWAS, Uruguay [02-036 RG/CHE/LA, ANII FCE 2007188]
- FONDECYT, Chile [1071068, 7070282]
In the search of new therapeutic tools for the treatment of American Trypanosomiasis, the largest parasitic disease burden in the American continent, three series of novel ruthenium complexes of the formula [RuCl2(HL)(2)], [RuCl3(dmso)(HL)] and [RuCl(PPh3)(L)(2)] with bioactive 5-nitrofuryl containing thiosemicarbazones; as ligands (HL neutral, L monoanionic) were synthesized and characterized. Their in vitro growth inhibition activity against Trypanosoma cruzi and the effect of co-ligands in related physicochemical properties i.e. nitro moiety redox potential, lipophilicity and free radical scavenger capacity were evaluated. Results show that although a loss of activity was observed as a consequence of ruthenium complexation, lipophilicity and free radical scavenger capacity of the obtained complexes could be correlated to their trypanocidal effect. (C) 2009 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据